Celontin
- Product NDC
- 0071-0525
- 11-digit product format
- 000710525
- Labeler code
- 0071
- Product ID
- 0071-0525_5d3eee75-8d10-4969-b883-81b1d5d3ae97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methsuximide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Parke-Davis Div of Pfizer Inc
- Application
- NDA010596
- Marketing category
- NDA
- Marketing start
- 1957-02-08
- Substance
- METHSUXIMIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Celontin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHSUXIMIDE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0G76K8X6C0 |
| Rxcui | 197949, 207088 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0071-0525-24 | Celontin | 100 in 1 BOTTLE | CAPSULE | 100 | | 16 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0071-0525 | CELONTIN (METHSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC] | 15 | Current NDC, Legacy NDC, 1 package rows | 20250130_64a6ee88-c6b1-4e13-8208-b6772ef65a74.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0071-0525-24 | 00071052524 | 100 CAPSULE in 1 BOTTLE (0071-0525-24) | 100 capsule | 1957-02-08 | 0000-00-00 | No | No | Current |